Amity Institute of Biotechnology, Amity University of Haryana, Haryana
A number of new drugs associated with advanced level of diagnosis have been introduced in the Indian market. The market growth pattern will rise exponentially depending on the acceptability of the advanced diagnostics for therapy selection by the well informed customer. This paper suggests that the growth of personalized medicine in therapy selection will show significant increase if it is properly channelized by the medical practitioners and the health systems duly supported by the government policies.
personalized medicine, bioinformatics, genetic tests, companies providing genetic tests
